Terazosin Capsule
Product Images NDC 66267-389

5 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 66267-389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)
Chemical structure of Terazosin Hydrochloride depicting its molecular arrangement including aromatic rings, nitrogen atoms, and an attached hydrochloride group.*
FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

Figure 1 (Terazosin Hydrochloride Capsules 2)
Two line graphs comparing Terazosin and placebo over 3 months. The left graph shows mean change in total symptom score from baseline, with Terazosin decreasing steadily more than placebo. The right graph displays mean increase in peak flow rate (mL/sec) from baseline, where Terazosin shows greater improvement than placebo throughout the months. Sample sizes are 54 to 55 per group, with error bars indicated.*
FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

Figure 2 (Terazosin Hydrochloride Capsules 3)
A line graph depicting mean change from baseline over time in months, with data points shown from month 0 to month 30. The vertical axis represents mean change, decreasing from 0 to -7. Data points at earlier months show larger negative mean changes, leveling off with smaller changes at later months. Asterisks mark certain data points indicating significance or emphasis.*
FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

Figure 3 (Terazosin Hydrochloride Capsules 4)
A line graph showing mean change from baseline (in mL/sec) over 30 months, with points marked at various months from 0 to 30. The vertical axis measures mean change, and an asterisk indicates statistical significance at multiple points along the timeline.*
FDA Label Image

Pdp (66267 389 30)

Pdp (66267 389 30)
Label for Terazosin 2 mg capsules by NuCare Pharmaceuticals, Inc. The label shows the package contains 30 capsules, each containing Terazosin Hydrochloride equivalent to 2 mg Terazosin. It includes storage instructions at controlled temperature 68-77°F, a warning to keep out of reach of children, and dosage directions to take every number of hours per day as instructed by a doctor. The product number is P0389030 and the label notes 'Rx Only.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.